Genprex, Inc. Income Statement
GNPX|6 years of annual SEC 10-K data (FY2017-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Genprex, Inc. reported $0 in revenue and $31M in net loss for FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| SG&A Expense | $13.4M | $12.3M | $11.7M | $10.6M | $3.0M | $3.8M |
| R&D Expense | $17.6M | $11.5M | $9.0M | $7.3M | $289.9K | $354.9K |
| Operating Income | -$31.1M | -$23.8M | -$20.7M | -$18.0M | -$3.3M | -$4.1M |
| Interest Expense | - | - | - | - | $1.9K | $0 |
| Income Tax | $0 | $0 | - | - | - | - |
| Net Income | -$30.9M | -$23.7M | -$20.7M | -$17.9M | -$3.3M | -$4.1M |
| EPS (Basic) | -$22.56 | -$19.80 | -$0.44 | - | - | - |
| EPS (Diluted) | - | - | - | -$0.51 | -$0.29 | -$0.38 |
| Shares Outstanding | 1.5M | 1.2M | 47.9M | 43.1M | 11.7M | 11.4M |